348 related articles for article (PubMed ID: 10365798)
1. Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cells.
Akbar SM; Abe M; Masumoto T; Horiike N; Onji M
J Hepatol; 1999 May; 30(5):755-64. PubMed ID: 10365798
[TBL] [Abstract][Full Text] [Related]
2. Production of antibody to hepatitis B surface antigen (anti-HBs) by murine hepatitis B virus carriers: neonatal tolerance versus antigen presentation by dendritic cells.
Kurose K; Akbar SM; Yamamoto K; Onji M
Immunology; 1997 Dec; 92(4):494-500. PubMed ID: 9497491
[TBL] [Abstract][Full Text] [Related]
3. Prognostic importance of antigen-presenting dendritic cells during vaccine therapy in a murine hepatitis B virus carrier.
Akbar SK; Horiike N; Onji M
Immunology; 1999 Jan; 96(1):98-108. PubMed ID: 10233683
[TBL] [Abstract][Full Text] [Related]
4. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
[TBL] [Abstract][Full Text] [Related]
5. Production of hepatitis B surface antigen-pulsed dendritic cells from immunosuppressed murine hepatitis B virus carrier: evaluation of immunogenicity of antigen-pulsed dendritic cells in vivo.
Furukawa S; Akbar SM; Hasebe A; Horiike N; Onji M
Immunobiology; 2004; 209(7):551-7. PubMed ID: 15568619
[TBL] [Abstract][Full Text] [Related]
6. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
[TBL] [Abstract][Full Text] [Related]
7. Effect of the hepatitis B virus S‑ecdCD40L vaccine therapy in HBV transgenic mice: A vaccine‑induced activation of antigen presenting dendritic cells.
Guan H; Lan S; Wu J; Tang B; Xu Y
Mol Med Rep; 2017 Nov; 16(5):6102-6108. PubMed ID: 28849136
[TBL] [Abstract][Full Text] [Related]
8. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
[TBL] [Abstract][Full Text] [Related]
9. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of MHC class II antigen on dendritic cells from hepatitis B virus transgenic mice by interferon-gamma: abrogation of immune response defect to a T-cell-dependent antigen.
Akbar SM; Inaba K; Onji M
Immunology; 1996 Apr; 87(4):519-27. PubMed ID: 8675204
[TBL] [Abstract][Full Text] [Related]
11. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
12. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.
Akbar SM; Furukawa S; Hasebe A; Horiike N; Michitaka K; Onji M
Int J Mol Med; 2004 Aug; 14(2):295-9. PubMed ID: 15254781
[TBL] [Abstract][Full Text] [Related]
13. Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice.
Oka Y; Akbar SM; Horiike N; Joko K; Onji M
Immunology; 2001 May; 103(1):90-7. PubMed ID: 11380696
[TBL] [Abstract][Full Text] [Related]
14. HBV DNA vaccine with adjuvant cytokines induced specific immune responses against HBV infection.
Du DW; Jia ZS; Li GY; Zhou YY
World J Gastroenterol; 2003 Jan; 9(1):108-11. PubMed ID: 12508362
[TBL] [Abstract][Full Text] [Related]
15. Induction and maintenance of anti-HBs in immunosuppressed murine hepatitis B virus carriers by a novel vaccination approach: implications for use in hepatitis B virus-infected subjects with liver transplantation.
Furukawa S; Akbar SM; Hasebe A; Horiike N; Onji M
J Gastroenterol; 2004 Sep; 39(9):851-8. PubMed ID: 15565404
[TBL] [Abstract][Full Text] [Related]
16. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.
Wang X; Dong A; Xiao J; Zhou X; Mi H; Xu H; Zhang J; Wang B
Cell Mol Immunol; 2016 Nov; 13(6):850-861. PubMed ID: 26166767
[TBL] [Abstract][Full Text] [Related]
17. Functional implications of hepatitis B surface antigen (HBsAg) in the T cells of chronic HBV carriers.
Nagaraju K; Naik SR; Naik S
J Viral Hepat; 1997 Jul; 4(4):221-30. PubMed ID: 9278219
[TBL] [Abstract][Full Text] [Related]
18. Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine.
Krawczyk A; Ludwig C; Jochum C; Fiedler M; Heinemann FM; Shouval D; Roggendorf M; Roggendorf H; Lindemann M
Vaccine; 2014 Sep; 32(39):5077-82. PubMed ID: 24975813
[TBL] [Abstract][Full Text] [Related]
19. Low responsiveness of hepatitis B virus-transgenic mice in antibody response to T-cell-dependent antigen: defect in antigen-presenting activity of dendritic cells.
Akbar SM; Onji M; Inaba K; Yamamura K; Ohta Y
Immunology; 1993 Mar; 78(3):468-75. PubMed ID: 8478028
[TBL] [Abstract][Full Text] [Related]
20. HBsAg-induced antigen-specific T and B lymphocyte responses in chronic hepatitis B virus carriers and immune individuals.
Fernan A; Cayzer CJ; Cooksley WG
Clin Exp Immunol; 1989 May; 76(2):222-6. PubMed ID: 2788046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
